Tilray Brands (TLRY) EBIT Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 98.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 98.86% |
| Feb 28, 2026 | 96.53% |
| Nov 30, 2025 | 47.23% |
| Aug 31, 2025 | 105.72% |
| May 31, 2025 | -8,637.66% |
| Feb 28, 2025 | -825.64% |
| Nov 30, 2024 | -1.10% |
| Aug 31, 2024 | -6.43% |
| May 31, 2024 | 81.63% |
| Feb 29, 2024 | 93.20% |
| Nov 30, 2023 | 19.37% |
| Aug 31, 2023 | -62.25% |
| May 31, 2023 | 80.75% |
| Feb 28, 2023 | -6,574.42% |
| Nov 30, 2022 | 6.73% |
| Aug 31, 2022 | 69.47% |
| May 31, 2022 | -534.34% |
| Feb 28, 2022 | 24.82% |
| Nov 30, 2021 | -113.90% |
| Aug 31, 2021 | -718.61% |